King Vision® and GlideScope® in Difficult Airways
A Comparison of the King Vision® Channeled, King Vision® Non-Channeled, and Glidescope® Video Intubation Systems in Patients at Risk for Difficult Intubation - A Pilot Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Over 18 years of age
- Mallampati III-IV
- Neck circumference > 43cm
- Reduced mouth opening (< 4cm) or 3 Finger breath's (patient's own)
- Thyromental distance < 6cm
Exclusion Criteria:
- Mallampati I-II
- Neck circumference < 43cm
- Documented 'easy' intubation
- Previous history of failed intubation and failed bag-mask ventilation
- Under 18 years of age
- ASA IV
- Known unstable cervical spine injury
- Presentation for an emergency surgical procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Glidescope AVL
|
Patients were randomized into one of the three groups through a computer generated randomization schedule.
Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade.
Patients will only be tested with one device.
All patients will be intubated using a conventional ETT.
|
|
Experimental: King Vision Channeled VL
|
Patients were randomized into one of the three groups through a computer generated randomization schedule.
Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade.
Patients will only be tested with one device.
All patients will be intubated using a conventional ETT.
|
|
Experimental: King Vision Non-Channeled (Standard) VL
|
Patients were randomized into one of the three groups through a computer generated randomization schedule.
Patients in group A (N= 75) will be intubated using the GlideScope® AVL, patients in group B (N= 75) will be intubated using the King Vision Channeled VL; patients in group C (N=75) will be intubated using the King Vision Video Laryngoscope with Standard (non-channeled) Blade.
Patients will only be tested with one device.
All patients will be intubated using a conventional ETT.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Successful Tracheal Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL
Time Frame: During laryngoscopy and endotracheal tube placement
|
The overall intubation success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL
|
During laryngoscopy and endotracheal tube placement
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First-attempt Successful Intubation for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL
Time Frame: During laryngoscopy and endotracheal tube placement
|
The overall first-attempt success rates for all 3 video laryngoscopes - GSAVL, KVChVL and KVNChVL
|
During laryngoscopy and endotracheal tube placement
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Final Intubation Time for All 3 Video Laryngoscopes - GSAVL, KVChVL and KVNChVL
Time Frame: During laryngoscopy and endotracheal tube placement
|
Total time for placing the endotracheal tube (ETT) through the vocal cords
|
During laryngoscopy and endotracheal tube placement
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Carin A Hagberg, MD, The University of Texas MD Anderson Cancer Center
Publications and helpful links
General Publications
- Hagberg CA, Iannucci D, Goodrich A. A comparison of the glottic view obtained with the Macintosh Video Laryngoscope in anesthetized, paralyzed, apneic patients. Direct view vs video monitor. Anesthesiology 2003; 103: A1501.
- Hagberg C, Matuszczak M, Ellis S, et al. A randomized comparison of laryngoscopy techniques using the video laryngoscope and the traditional Macintosh laryngoscope in obese patients. Anesthesiology 2005; 103: A1420.
- Hagberg C, Vogt-Harenkamp C, Bogomolny Y, et al. A comparison of laryngoscopy techniques using the video laryngoscope and the traditional Macintosh laryngoscope in potentially difficult to intubate patients. Anesth Analg 2005; 100: S-212.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- HSC-MS-13-0024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.